Research Exclusivity. A. During the Research Term, MAXYGEN will not collaborate with any entity nor undertake any research activities not for the direct benefit of PIONEER with the intent of using Shuffling Technology to [*******] ("the Exclusive Trait Areas").
Research Exclusivity. During the Research Term, DIVERSA will not collaborate with or license the rights to any Third Party to use any [*****] Enzyme in a Research [*****] to convert a Research [*****] to a [*****], as defined in Appendix [*****], so long as DOW satisfies the diligence obligations set forth in the [*****] Plan with respect to the development of the applicable [*****] Enzyme. During the Research Term, DOW will not collaborate with or license the rights to any Third Party to evolve any enzyme in a Research [*****] to convert a Research [*****] to a [*****], as defined in Appendix [*****].
Research Exclusivity. 2.7.1 Exclusive and Co-Exclusive Trait Categories. During the ------------------------------------------- Research Term, Maxygen (i) will conduct research exclusively with Zeneca in the Trait Categories of [*******] and (ii) may only conduct research with Zeneca and up to [*******] other [*******] in the Trait Categories of [*******].
Research Exclusivity. During the Research Term, the Parties agree to cooperate exclusively with each other in carrying out research and development relating to uPA Inhibitors. Neither Party shall, during the Research Term, carry out any research in the Field relating to the discovery of uPA Inhibitors except pursuant to this Agreement unless the Parties mutually agree otherwise in writing. Neither Party shall enter into any agreement with a Third Party which would prevent it from performing its obligations under this Agreement.
Research Exclusivity. ProdiGene agrees that it will not perform research and/or development or enter into any commercial agreement in or related to an Elected Research Program with any third party during the term of such Elected Research Program, after which ProdiGene, subject to its obligations of confidentiality, exclusivity and to proprietary rights granted to GCI hereunder, may continue such research without regard to GCI.
Research Exclusivity. During the Term and continuing thereafter for a period of *** (***) ***, Pharmacopeia agrees that it will not ***.
Research Exclusivity. After the Effective Date and until two (2) years after the end of the Research Term, subject to Sequana's existing agreements with third parties relating to asthma patient samples and such further agreements as the JRC may approve, neither Party will conduct any research in the Field with any other third party except as provided according to Article 6.2; provided, however, BI may collaborate with research and development relating to Asthma with third parties, outside the Field. Notwithstanding the above, either party may conduct research and commercialization activities with respect to diseases other than Asthma, alone or with third parties. Notwithstanding Article 6.1.1, in the event that Sequana materially breaches the Agreement, and BI terminates this Agreement pursuant to Section 12.2, BI may enter into collaborations with third parties to conduct research in the Field.
Research Exclusivity. During the Research Term, DIVERSA will not collaborate with or license the rights to any Third Party to use any Licensed Enzyme in the Approved Fields, so long as the LLC satisfies the diligence obligations set forth in the Work Plan with respect to the development of the applicable Licensed Enzyme. During the Research Term, the LLC will not collaborate with or license the rights to any Third Party to discover or evolve any enzyme in the Approved Fields.
Research Exclusivity
